Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Joubert

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
ACS Omega|August 2, 2021
Synthesis and Biological Evaluation of Thiazole-Based Derivatives as Potential Acetylcholinesterase InhibitorsAya Y Hemaida, Ghada S Hassan, Azza R Maarouf, et al.
Scientific Reports|December 26, 2019
Crystal structure, Hirshfeld surface analysis and DFT studies of 5-(adamantan-1-yl)-3-[(4-chlorobenzyl)sulfanyl]-4-methyl-4H-1,2,4-triazole, a potential 11β-HSD1 inhibitorLamya H Al-Wahaibi, Jacques Joubert, Olivier Blacque, et al.
European Journal of Medicinal Chemistry|October 17, 2016
Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's diseaseJacques Joubert, Germaine B Foka, Benjamin P Repsold, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 24, 2009
Telestroke in stroke survivorsJacques Joubert, Lynette B Joubert, Elizabeth Medeiros de Bustos, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 21, 2019
ICARUSS: An effective model for risk factor management in stroke survivorsJacques Joubert, Stephen M Davis, Geoffrey A Donnan, et al.
European Journal of Medicinal Chemistry|April 29, 2014
Polycyclic propargylamine and acetylene derivatives as multifunctional neuroprotective agentsFrank T Zindo, Quinton R Barber, Jacques Joubert, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 20, 2021
Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agentsSheunopa C Mzezewa, Sylvester I Omoruyi, Luke S Zondagh, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|April 26, 2012
S-nitrosylation and attenuation of excessive calcium flux by pentacycloundecane derivativesHendrik J R Lemmer, Jacques Joubert, Sandra van Dyk, et al.
International Journal of Environmental Research and Public Health|November 25, 2020
Towards the Development of an Intervention to Address Social Determinants of Non-Communicable Disease in Kerala, India: A Mixed Methods StudyMartin Webber, Jacques Joubert, Meredith Fendt-Newlin, et al.
European Journal of Medicinal Chemistry|December 4, 2018
Design, synthesis and evaluation of pentacycloundecane and hexacycloundecane propargylamine derivatives as multifunctional neuroprotective agentsFrank T Zindo, Sarel F Malan, Sylvester I Omoruyi, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
ACS Omega|August 2, 2021
Synthesis and Biological Evaluation of Thiazole-Based Derivatives as Potential Acetylcholinesterase InhibitorsAya Y Hemaida, Ghada S Hassan, Azza R Maarouf, et al.
Scientific Reports|December 26, 2019
Crystal structure, Hirshfeld surface analysis and DFT studies of 5-(adamantan-1-yl)-3-[(4-chlorobenzyl)sulfanyl]-4-methyl-4H-1,2,4-triazole, a potential 11β-HSD1 inhibitorLamya H Al-Wahaibi, Jacques Joubert, Olivier Blacque, et al.
European Journal of Medicinal Chemistry|October 17, 2016
Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's diseaseJacques Joubert, Germaine B Foka, Benjamin P Repsold, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 24, 2009
Telestroke in stroke survivorsJacques Joubert, Lynette B Joubert, Elizabeth Medeiros de Bustos, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 21, 2019
ICARUSS: An effective model for risk factor management in stroke survivorsJacques Joubert, Stephen M Davis, Geoffrey A Donnan, et al.
European Journal of Medicinal Chemistry|April 29, 2014
Polycyclic propargylamine and acetylene derivatives as multifunctional neuroprotective agentsFrank T Zindo, Quinton R Barber, Jacques Joubert, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 20, 2021
Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agentsSheunopa C Mzezewa, Sylvester I Omoruyi, Luke S Zondagh, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|April 26, 2012
S-nitrosylation and attenuation of excessive calcium flux by pentacycloundecane derivativesHendrik J R Lemmer, Jacques Joubert, Sandra van Dyk, et al.
International Journal of Environmental Research and Public Health|November 25, 2020
Towards the Development of an Intervention to Address Social Determinants of Non-Communicable Disease in Kerala, India: A Mixed Methods StudyMartin Webber, Jacques Joubert, Meredith Fendt-Newlin, et al.
European Journal of Medicinal Chemistry|December 4, 2018
Design, synthesis and evaluation of pentacycloundecane and hexacycloundecane propargylamine derivatives as multifunctional neuroprotective agentsFrank T Zindo, Sarel F Malan, Sylvester I Omoruyi, et al.
Pageof 7